

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.86342150 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.62432659 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62432659 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.25993733 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25993733 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.88334595 |
| 7 | drug metabolic process (GO:0017144) | 6.68866253 |
| 8 | oxidative demethylation (GO:0070989) | 6.45664976 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.25004100 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.24473010 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.24473010 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.24473010 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.11617885 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.87917700 |
| 15 | * bile acid biosynthetic process (GO:0006699) | 5.83000976 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.78335750 |
| 17 | urea metabolic process (GO:0019627) | 5.74076056 |
| 18 | urea cycle (GO:0000050) | 5.74076056 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.67753052 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.66014804 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.48889126 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.48129338 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.47087070 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.46487224 |
| 25 | cysteine metabolic process (GO:0006534) | 5.43177212 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.41229476 |
| 27 | protein carboxylation (GO:0018214) | 5.41229476 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.38355682 |
| 29 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.34788762 |
| 30 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.34788762 |
| 31 | regulation of humoral immune response (GO:0002920) | 5.33169162 |
| 32 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.32070531 |
| 33 | negative regulation of protein activation cascade (GO:2000258) | 5.29964009 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 5.27321627 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 5.15885563 |
| 36 | regulation of complement activation (GO:0030449) | 5.10693162 |
| 37 | regulation of plasminogen activation (GO:0010755) | 5.07032712 |
| 38 | * bile acid metabolic process (GO:0008206) | 5.00364091 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.99346129 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94460441 |
| 41 | acute-phase response (GO:0006953) | 4.89666294 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.87657460 |
| 43 | ethanol metabolic process (GO:0006067) | 4.86099345 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.82370715 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.80442450 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.75377438 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.75336228 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.74140924 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.74140924 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.74140924 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.67577525 |
| 52 | S-adenosylmethionine metabolic process (GO:0046500) | 4.66452197 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.61707701 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.61707701 |
| 55 | phenylpropanoid metabolic process (GO:0009698) | 4.61341817 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.59395342 |
| 57 | lysine catabolic process (GO:0006554) | 4.58756999 |
| 58 | lysine metabolic process (GO:0006553) | 4.58756999 |
| 59 | negative regulation of blood coagulation (GO:0030195) | 4.53241620 |
| 60 | negative regulation of hemostasis (GO:1900047) | 4.53241620 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.51029069 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 4.51029069 |
| 63 | phospholipid efflux (GO:0033700) | 4.49903300 |
| 64 | glycine metabolic process (GO:0006544) | 4.48227935 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.46586237 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.43078614 |
| 67 | coenzyme catabolic process (GO:0009109) | 4.42351647 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.40695211 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 4.37628772 |
| 70 | flavonoid metabolic process (GO:0009812) | 4.35317493 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.33350246 |
| 72 | amine catabolic process (GO:0009310) | 4.33350246 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.29658998 |
| 74 | cellular glucuronidation (GO:0052695) | 4.28787415 |
| 75 | glutamate metabolic process (GO:0006536) | 4.28591308 |
| 76 | alkaloid metabolic process (GO:0009820) | 4.26156052 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 4.22189452 |
| 78 | cholesterol efflux (GO:0033344) | 4.22106823 |
| 79 | * bile acid and bile salt transport (GO:0015721) | 4.19353992 |
| 80 | ethanol oxidation (GO:0006069) | 4.17885787 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.15708985 |
| 82 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.10478566 |
| 83 | negative regulation of coagulation (GO:0050819) | 4.09968047 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.09179551 |
| 85 | negative regulation of wound healing (GO:0061045) | 4.08890253 |
| 86 | negative regulation of complement activation (GO:0045916) | 4.08745270 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 4.08457643 |
| 88 | serine family amino acid biosynthetic process (GO:0009070) | 4.06801382 |
| 89 | hormone catabolic process (GO:0042447) | 4.04859595 |
| 90 | fibrinolysis (GO:0042730) | 4.03740170 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.99448771 |
| 92 | aldehyde catabolic process (GO:0046185) | 3.99416616 |
| 93 | arginine metabolic process (GO:0006525) | 3.98128271 |
| 94 | drug catabolic process (GO:0042737) | 3.90495327 |
| 95 | blood coagulation, intrinsic pathway (GO:0007597) | 3.88617396 |
| 96 | complement activation, classical pathway (GO:0006958) | 3.83701611 |
| 97 | positive regulation of blood coagulation (GO:0030194) | 3.83381743 |
| 98 | positive regulation of hemostasis (GO:1900048) | 3.83381743 |
| 99 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.82007169 |
| 100 | ketone body metabolic process (GO:1902224) | 3.81469880 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.81120868 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.80180473 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.80180473 |
| 104 | cofactor catabolic process (GO:0051187) | 3.80099888 |
| 105 | complement activation (GO:0006956) | 3.79765862 |
| 106 | protein activation cascade (GO:0072376) | 3.77596192 |
| 107 | cytolysis (GO:0019835) | 3.74859155 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.74800784 |
| 109 | organic acid catabolic process (GO:0016054) | 3.74800784 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.73968106 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73631025 |
| 112 | acetyl-CoA metabolic process (GO:0006084) | 3.73406122 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.71255158 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.70863187 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.70863187 |
| 116 | regulation of cholesterol homeostasis (GO:2000188) | 3.68430770 |
| 117 | regulation of acute inflammatory response (GO:0002673) | 3.68344605 |
| 118 | sodium-independent organic anion transport (GO:0043252) | 3.67895232 |
| 119 | sterol homeostasis (GO:0055092) | 3.67704704 |
| 120 | short-chain fatty acid metabolic process (GO:0046459) | 3.66369844 |
| 121 | negative regulation of lipase activity (GO:0060192) | 3.64402417 |
| 122 | response to mercury ion (GO:0046689) | 3.61820292 |
| 123 | plasma lipoprotein particle organization (GO:0071827) | 3.60788371 |
| 124 | acute inflammatory response (GO:0002526) | 3.59043192 |
| 125 | protein-lipid complex assembly (GO:0065005) | 3.58054118 |
| 126 | opsonization (GO:0008228) | 3.56175201 |
| 127 | regulation of apoptotic cell clearance (GO:2000425) | 3.55226957 |
| 128 | NAD biosynthetic process (GO:0009435) | 3.53228851 |
| 129 | positive regulation of coagulation (GO:0050820) | 3.51673720 |
| 130 | xenobiotic metabolic process (GO:0006805) | 3.47106487 |
| 131 | intestinal cholesterol absorption (GO:0030299) | 3.46823384 |
| 132 | arginine catabolic process (GO:0006527) | 3.36906156 |
| 133 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.36680207 |
| 134 | oxaloacetate metabolic process (GO:0006107) | 3.34023651 |
| 135 | drug transmembrane transport (GO:0006855) | 3.32198371 |
| 136 | exogenous drug catabolic process (GO:0042738) | 11.1580596 |
| 137 | omega-hydroxylase P450 pathway (GO:0097267) | 10.4065301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41714627 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19776105 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.09933317 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.54046043 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.30927770 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.11361436 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.69230455 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.10684678 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.02383329 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08118347 |
| 11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9093705 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96110853 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92340151 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64193601 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53292045 |
| 16 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48917122 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44405235 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41332633 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21655006 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20084350 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20055450 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18017990 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08265238 |
| 24 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07421832 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07084139 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05656333 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03484216 |
| 28 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.02513178 |
| 29 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.02064612 |
| 30 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.99705764 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99251271 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98640933 |
| 33 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97737266 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96656242 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96037635 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95669593 |
| 37 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94877912 |
| 38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92742542 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87849115 |
| 40 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87124700 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86173140 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84897461 |
| 43 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84642392 |
| 44 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84618180 |
| 45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83757108 |
| 46 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83507335 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83149361 |
| 48 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83007102 |
| 49 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.82933464 |
| 50 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80971242 |
| 51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79056470 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78532438 |
| 53 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78050179 |
| 54 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.77191544 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77182235 |
| 56 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77014689 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.76047674 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75938342 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74528529 |
| 60 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74375298 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.74133040 |
| 62 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.73947039 |
| 63 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73699575 |
| 64 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.72985857 |
| 65 | NFYB_21822215_ChIP-Seq_K562_Human | 0.72136639 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71448375 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69663689 |
| 68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69380324 |
| 69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68541267 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68541267 |
| 71 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.67842170 |
| 72 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.67692185 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67393044 |
| 74 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67107872 |
| 75 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.65423641 |
| 76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.65100680 |
| 77 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.65100680 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.64717859 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.64516265 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 0.64320711 |
| 81 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.63568291 |
| 82 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.63285511 |
| 83 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63129238 |
| 84 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.62505354 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61869786 |
| 86 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.60732393 |
| 87 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59424038 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.59001234 |
| 89 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.58682532 |
| 90 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.58350425 |
| 91 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58214741 |
| 92 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.57757927 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57530550 |
| 94 | TBL1_22424771_ChIP-Seq_293T_Human | 0.57202336 |
| 95 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56915857 |
| 96 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.56785163 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56676992 |
| 98 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.56431180 |
| 99 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.55676228 |
| 100 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54916535 |
| 101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.54636247 |
| 102 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54610365 |
| 103 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.54271474 |
| 104 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53851660 |
| 105 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.52964585 |
| 106 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52723331 |
| 107 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51771624 |
| 108 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.51484411 |
| 109 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51337567 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51315570 |
| 111 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.49850708 |
| 112 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49743070 |
| 113 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49587079 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49292720 |
| 115 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48499495 |
| 116 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.46922865 |
| 117 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.46325117 |
| 118 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46256950 |
| 119 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46239493 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45931065 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.44845602 |
| 122 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44016337 |
| 123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43881642 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43164784 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42872074 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42821622 |
| 127 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42305958 |
| 128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.41049334 |
| 129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40887030 |
| 130 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40781339 |
| 131 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.39433659 |
| 132 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38628433 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38295509 |
| 134 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37820251 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.37063566 |
| 136 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.37015754 |
| 137 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36904450 |
| 138 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36721713 |
| 139 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36178887 |
| 140 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.35556052 |
| 141 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34828904 |
| 142 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.34553276 |
| 143 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34526188 |
| 144 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34296985 |
| 145 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34116045 |
| 146 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.33360160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.44541921 |
| 2 | MP0005360_urolithiasis | 7.67580079 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.29404036 |
| 4 | * MP0005365_abnormal_bile_salt | 5.97951150 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13136792 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.37912954 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.63818850 |
| 8 | * MP0003252_abnormal_bile_duct | 3.58157497 |
| 9 | MP0009840_abnormal_foam_cell | 3.22632595 |
| 10 | MP0005083_abnormal_biliary_tract | 3.17154423 |
| 11 | MP0003195_calcinosis | 2.89152973 |
| 12 | MP0005332_abnormal_amino_acid | 2.75952262 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.62990332 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.25888410 |
| 15 | * MP0000609_abnormal_liver_physiology | 2.17131670 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.14650415 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.09913987 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.00785504 |
| 19 | MP0003868_abnormal_feces_composition | 1.95656288 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84792054 |
| 21 | MP0001764_abnormal_homeostasis | 1.67487109 |
| 22 | MP0009697_abnormal_copulation | 1.66999612 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57822542 |
| 24 | MP0003011_delayed_dark_adaptation | 1.39515000 |
| 25 | MP0005451_abnormal_body_composition | 1.38815963 |
| 26 | MP0002132_abnormal_respiratory_system | 1.33001787 |
| 27 | MP0003186_abnormal_redox_activity | 1.26194301 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.24312732 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.22185667 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.16932833 |
| 31 | MP0005647_abnormal_sex_gland | 1.16832776 |
| 32 | * MP0000598_abnormal_liver_morphology | 1.16615869 |
| 33 | MP0000604_amyloidosis | 1.09017000 |
| 34 | MP0002254_reproductive_system_inflammat | 1.07022627 |
| 35 | MP0009764_decreased_sensitivity_to | 1.06192785 |
| 36 | MP0009763_increased_sensitivity_to | 1.03230021 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.97847212 |
| 38 | MP0002282_abnormal_trachea_morphology | 0.96663824 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.92395711 |
| 40 | MP0005187_abnormal_penis_morphology | 0.91912962 |
| 41 | MP0008469_abnormal_protein_level | 0.89587691 |
| 42 | MP0005408_hypopigmentation | 0.89020153 |
| 43 | MP0001915_intracranial_hemorrhage | 0.88417211 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.87579483 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 0.83170235 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 0.80979847 |
| 47 | MP0005376_homeostasis/metabolism_phenot | 0.80324586 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.79057645 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.76737956 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 0.76711122 |
| 51 | * MP0002078_abnormal_glucose_homeostasis | 0.76322331 |
| 52 | MP0002249_abnormal_larynx_morphology | 0.74889992 |
| 53 | MP0005670_abnormal_white_adipose | 0.73673853 |
| 54 | MP0002971_abnormal_brown_adipose | 0.72601080 |
| 55 | MP0001661_extended_life_span | 0.71544814 |
| 56 | MP0005334_abnormal_fat_pad | 0.70529594 |
| 57 | MP0004130_abnormal_muscle_cell | 0.69555522 |
| 58 | MP0003690_abnormal_glial_cell | 0.68439633 |
| 59 | MP0005535_abnormal_body_temperature | 0.68382351 |
| 60 | MP0005266_abnormal_metabolism | 0.65308699 |
| 61 | MP0009053_abnormal_anal_canal | 0.64978669 |
| 62 | MP0003329_amyloid_beta_deposits | 0.63129386 |
| 63 | MP0003879_abnormal_hair_cell | 0.62603369 |
| 64 | MP0005023_abnormal_wound_healing | 0.62260588 |
| 65 | MP0000639_abnormal_adrenal_gland | 0.61949161 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 0.59320391 |
| 67 | MP0001756_abnormal_urination | 0.57721604 |
| 68 | MP0005448_abnormal_energy_balance | 0.56917311 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.53938733 |
| 70 | MP0002928_abnormal_bile_duct | 0.50398080 |
| 71 | MP0002332_abnormal_exercise_endurance | 0.49481137 |
| 72 | MP0005395_other_phenotype | 0.49357838 |
| 73 | MP0002822_catalepsy | 0.49172907 |
| 74 | MP0003718_maternal_effect | 0.46603199 |
| 75 | MP0004381_abnormal_hair_follicle | 0.46547869 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.45154636 |
| 77 | MP0003724_increased_susceptibility_to | 0.45001358 |
| 78 | MP0008874_decreased_physiological_sensi | 0.44850197 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.44563641 |
| 80 | MP0008873_increased_physiological_sensi | 0.43853911 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.43848827 |
| 82 | MP0003436_decreased_susceptibility_to | 0.43787489 |
| 83 | MP0000467_abnormal_esophagus_morphology | 0.42959775 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.42260095 |
| 85 | MP0001851_eye_inflammation | 0.41736560 |
| 86 | MP0003953_abnormal_hormone_level | 0.41423065 |
| 87 | MP0005248_abnormal_Harderian_gland | 0.41282035 |
| 88 | MP0009785_altered_susceptibility_to | 0.40984403 |
| 89 | MP0003075_altered_response_to | 0.39752952 |
| 90 | MP0000579_abnormal_nail_morphology | 0.38719050 |
| 91 | MP0005166_decreased_susceptibility_to | 0.38145238 |
| 92 | MP0009672_abnormal_birth_weight | 0.37213979 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.36700988 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.36700988 |
| 95 | MP0000566_synostosis | 0.35932070 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.35812708 |
| 97 | MP0008872_abnormal_physiological_respon | 0.34761955 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.34534913 |
| 99 | MP0002796_impaired_skin_barrier | 0.33858083 |
| 100 | MP0006082_CNS_inflammation | 0.33491033 |
| 101 | MP0009115_abnormal_fat_cell | 0.31773195 |
| 102 | MP0000249_abnormal_blood_vessel | 0.31753064 |
| 103 | MP0002168_other_aberrant_phenotype | 0.31718018 |
| 104 | MP0001853_heart_inflammation | 0.31662620 |
| 105 | MP0001243_abnormal_dermal_layer | 0.31188067 |
| 106 | MP0004883_abnormal_blood_vessel | 0.31175948 |
| 107 | MP0000230_abnormal_systemic_arterial | 0.31151964 |
| 108 | MP0002970_abnormal_white_adipose | 0.30353762 |
| 109 | MP0002128_abnormal_blood_circulation | 0.28903421 |
| 110 | MP0001881_abnormal_mammary_gland | 0.28322049 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.27542783 |
| 112 | MP0000920_abnormal_myelination | 0.26234930 |
| 113 | MP0000427_abnormal_hair_cycle | 0.25481586 |
| 114 | MP0005197_abnormal_uvea_morphology | 0.25462329 |
| 115 | MP0005164_abnormal_response_to | 0.25350077 |
| 116 | MP0003878_abnormal_ear_physiology | 0.25268576 |
| 117 | MP0005377_hearing/vestibular/ear_phenot | 0.25268576 |
| 118 | MP0003632_abnormal_nervous_system | 0.25195182 |
| 119 | MP0003633_abnormal_nervous_system | 0.25135676 |
| 120 | MP0002060_abnormal_skin_morphology | 0.24429239 |
| 121 | MP0005595_abnormal_vascular_smooth | 0.23571690 |
| 122 | MP0002090_abnormal_vision | 0.23433414 |
| 123 | MP0004272_abnormal_basement_membrane | 0.20224272 |
| 124 | MP0003631_nervous_system_phenotype | 0.19497463 |
| 125 | MP0000371_diluted_coat_color | 0.19460503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.57316507 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.44857954 |
| 3 | * Intrahepatic cholestasis (HP:0001406) | 7.06255982 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.75225351 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.74028509 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.59909791 |
| 7 | Xanthomatosis (HP:0000991) | 6.39051815 |
| 8 | Complement deficiency (HP:0004431) | 5.59424716 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.56913477 |
| 10 | Joint hemorrhage (HP:0005261) | 4.91659742 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.87409110 |
| 12 | Epidermoid cyst (HP:0200040) | 4.70058434 |
| 13 | Hyperammonemia (HP:0001987) | 4.63049750 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.61179953 |
| 15 | Hyperglycinemia (HP:0002154) | 4.54399355 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.46481526 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.26170262 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.25732173 |
| 19 | Ketosis (HP:0001946) | 4.25215783 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17228467 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.16597364 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10459383 |
| 23 | Abnormality of complement system (HP:0005339) | 4.07997566 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.96733771 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.96733771 |
| 26 | Hyperglycinuria (HP:0003108) | 3.94924267 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.91818388 |
| 28 | * Fat malabsorption (HP:0002630) | 3.90000834 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86121544 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.82834465 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.71632048 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35698549 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30411532 |
| 34 | Steatorrhea (HP:0002570) | 3.19937765 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.14444186 |
| 36 | * Hyperbilirubinemia (HP:0002904) | 3.12955665 |
| 37 | Spontaneous abortion (HP:0005268) | 3.12284081 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.10931054 |
| 39 | Hypochromic microcytic anemia (HP:0004840) | 3.05174888 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04517132 |
| 41 | Myocardial infarction (HP:0001658) | 3.04404099 |
| 42 | Ketoacidosis (HP:0001993) | 3.03422669 |
| 43 | Skin nodule (HP:0200036) | 2.91929996 |
| 44 | Osteomalacia (HP:0002749) | 2.80492460 |
| 45 | Acanthocytosis (HP:0001927) | 2.79434308 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.79411691 |
| 47 | Metabolic acidosis (HP:0001942) | 2.74431166 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.65358466 |
| 49 | Neonatal hypoglycemia (HP:0001998) | 2.64889102 |
| 50 | Vascular calcification (HP:0004934) | 2.60324938 |
| 51 | Lethargy (HP:0001254) | 2.59296093 |
| 52 | Hypoglycemic seizures (HP:0002173) | 2.57056098 |
| 53 | Fair hair (HP:0002286) | 2.55514622 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.55018127 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55018127 |
| 56 | Glomerulonephritis (HP:0000099) | 2.52766247 |
| 57 | Spastic diplegia (HP:0001264) | 2.47748836 |
| 58 | Pulmonary embolism (HP:0002204) | 2.47560988 |
| 59 | Mitral stenosis (HP:0001718) | 2.46427031 |
| 60 | * Hepatocellular carcinoma (HP:0001402) | 2.44017267 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43909318 |
| 62 | Purpura (HP:0000979) | 2.42989301 |
| 63 | Cerebral edema (HP:0002181) | 2.41249989 |
| 64 | Gout (HP:0001997) | 2.40160292 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.38082778 |
| 66 | Cholecystitis (HP:0001082) | 2.38082778 |
| 67 | Irritability (HP:0000737) | 2.36637338 |
| 68 | Neonatal onset (HP:0003623) | 2.36524477 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.30770988 |
| 70 | Amyloidosis (HP:0011034) | 2.29276710 |
| 71 | Malnutrition (HP:0004395) | 2.27772140 |
| 72 | Gingival bleeding (HP:0000225) | 2.27129749 |
| 73 | * Conjugated hyperbilirubinemia (HP:0002908) | 2.26370177 |
| 74 | Esophageal varix (HP:0002040) | 2.25274683 |
| 75 | Menorrhagia (HP:0000132) | 2.18125873 |
| 76 | Joint swelling (HP:0001386) | 2.17130919 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.16027620 |
| 78 | Pancreatitis (HP:0001733) | 2.14315089 |
| 79 | Late onset (HP:0003584) | 2.12417724 |
| 80 | Thrombophlebitis (HP:0004418) | 2.11635099 |
| 81 | Epistaxis (HP:0000421) | 2.11542134 |
| 82 | Enlarged kidneys (HP:0000105) | 2.11275004 |
| 83 | Brushfield spots (HP:0001088) | 2.11201355 |
| 84 | Poikilocytosis (HP:0004447) | 2.10439318 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09513746 |
| 86 | * Abnormal gallbladder morphology (HP:0012437) | 2.08141358 |
| 87 | Vomiting (HP:0002013) | 2.03993409 |
| 88 | Opisthotonus (HP:0002179) | 2.03785015 |
| 89 | Hemorrhage of the eye (HP:0011885) | 2.02406281 |
| 90 | Abnormal biliary tract physiology (HP:0012439) | 2.00706969 |
| 91 | Bile duct proliferation (HP:0001408) | 2.00706969 |
| 92 | Generalized aminoaciduria (HP:0002909) | 1.99825481 |
| 93 | Rickets (HP:0002748) | 1.95512392 |
| 94 | * Cholelithiasis (HP:0001081) | 1.94833548 |
| 95 | Increased serum ferritin (HP:0003281) | 1.91648767 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.91463523 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89817787 |
| 98 | Increased mean platelet volume (HP:0011877) | 1.88544963 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 1.88330292 |
| 100 | Renal cortical cysts (HP:0000803) | 1.88048704 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 1.86429863 |
| 102 | Arthropathy (HP:0003040) | 1.84214165 |
| 103 | Elevated hepatic transaminases (HP:0002910) | 1.83206540 |
| 104 | Hydroxyprolinuria (HP:0003080) | 1.82035208 |
| 105 | Abnormality of proline metabolism (HP:0010907) | 1.82035208 |
| 106 | Alkalosis (HP:0001948) | 1.81499977 |
| 107 | Reduced antithrombin III activity (HP:0001976) | 1.80019066 |
| 108 | Abnormal delivery (HP:0001787) | 1.80014615 |
| 109 | Status epilepticus (HP:0002133) | 1.78752731 |
| 110 | Nephritis (HP:0000123) | 1.78474264 |
| 111 | Abnormality of vitamin metabolism (HP:0100508) | 1.77372642 |
| 112 | Hyperglycemia (HP:0003074) | 1.76449357 |
| 113 | Generalized hypopigmentation of hair (HP:0011358) | 1.76340273 |
| 114 | Hyperphosphaturia (HP:0003109) | 1.75978655 |
| 115 | * Abnormality of the gallbladder (HP:0005264) | 1.72667769 |
| 116 | Acute hepatic failure (HP:0006554) | 1.71078210 |
| 117 | Abnormality of alanine metabolism (HP:0010916) | 1.70551542 |
| 118 | Hyperalaninemia (HP:0003348) | 1.70551542 |
| 119 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.70551542 |
| 120 | Abnormal platelet volume (HP:0011876) | 1.69378734 |
| 121 | Glycosuria (HP:0003076) | 1.65830741 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 1.65830741 |
| 123 | Gangrene (HP:0100758) | 1.62734558 |
| 124 | Abnormality of the Achilles tendon (HP:0005109) | 1.62421225 |
| 125 | Cerebral palsy (HP:0100021) | 1.58728346 |
| 126 | * Elevated alkaline phosphatase (HP:0003155) | 1.57680886 |
| 127 | Blue irides (HP:0000635) | 1.57618798 |
| 128 | Increased serum pyruvate (HP:0003542) | 1.53737940 |
| 129 | Bifid scrotum (HP:0000048) | 1.52038494 |
| 130 | Hematuria (HP:0000790) | 1.49279813 |
| 131 | Spontaneous hematomas (HP:0007420) | 1.49091254 |
| 132 | Anorexia (HP:0002039) | 1.47594275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.92054169 |
| 2 | FGFR4 | 4.62724758 |
| 3 | SIK1 | 4.60200015 |
| 4 | ERN1 | 4.24600827 |
| 5 | TAOK3 | 3.27045061 |
| 6 | INSRR | 3.22723418 |
| 7 | ERBB4 | 3.03666965 |
| 8 | MAP2K4 | 2.32875164 |
| 9 | PKN2 | 2.19065273 |
| 10 | MST1R | 2.14479236 |
| 11 | PIK3CG | 2.02281590 |
| 12 | FLT3 | 1.92067169 |
| 13 | MAPK11 | 1.91942670 |
| 14 | LATS1 | 1.74975642 |
| 15 | TYK2 | 1.73950830 |
| 16 | TRIB3 | 1.67085527 |
| 17 | NLK | 1.63620425 |
| 18 | DAPK2 | 1.59643827 |
| 19 | FRK | 1.53155153 |
| 20 | FGFR2 | 1.50457276 |
| 21 | PTK6 | 1.48974169 |
| 22 | AKT3 | 1.48627637 |
| 23 | OBSCN | 1.47590648 |
| 24 | FER | 1.45526936 |
| 25 | ABL2 | 1.45166596 |
| 26 | NEK9 | 1.42790487 |
| 27 | NTRK3 | 1.41389267 |
| 28 | KDR | 1.26003782 |
| 29 | MAP3K7 | 1.25439968 |
| 30 | JAK2 | 1.25433509 |
| 31 | PRKAA2 | 1.16272728 |
| 32 | CAMKK2 | 1.15437422 |
| 33 | PINK1 | 1.11780445 |
| 34 | TNK2 | 1.11487389 |
| 35 | ERBB2 | 1.08430599 |
| 36 | PDGFRA | 1.07094866 |
| 37 | JAK1 | 1.06990382 |
| 38 | MAP3K10 | 1.06167561 |
| 39 | PRKG1 | 1.05070876 |
| 40 | TBK1 | 1.01793347 |
| 41 | MAP3K14 | 1.00533290 |
| 42 | MAP2K3 | 0.98382491 |
| 43 | GRK6 | 0.96987504 |
| 44 | MAPK4 | 0.96476131 |
| 45 | PRKCZ | 0.91824366 |
| 46 | MAPK15 | 0.90915311 |
| 47 | MAP3K2 | 0.88526512 |
| 48 | STK38 | 0.86758820 |
| 49 | MET | 0.86419763 |
| 50 | ARAF | 0.85657031 |
| 51 | STK38L | 0.84648801 |
| 52 | EPHB1 | 0.82337240 |
| 53 | CAMK1D | 0.81283574 |
| 54 | PRKACA | 0.81214758 |
| 55 | CDK6 | 0.80222154 |
| 56 | PDK2 | 0.77850556 |
| 57 | EPHA3 | 0.77454362 |
| 58 | MAPK12 | 0.77039416 |
| 59 | PRKACG | 0.75739125 |
| 60 | MAP3K3 | 0.75150180 |
| 61 | ACVR1B | 0.73487473 |
| 62 | TIE1 | 0.73154248 |
| 63 | LMTK2 | 0.73004707 |
| 64 | CAMK2G | 0.70204742 |
| 65 | DYRK1B | 0.69660435 |
| 66 | PRKAA1 | 0.69043081 |
| 67 | CSK | 0.68425713 |
| 68 | GSK3A | 0.67824375 |
| 69 | IRAK3 | 0.67074297 |
| 70 | WNK3 | 0.66185624 |
| 71 | SGK3 | 0.65456459 |
| 72 | BRSK2 | 0.64817543 |
| 73 | PRPF4B | 0.64812011 |
| 74 | MAP3K11 | 0.64015745 |
| 75 | FGFR3 | 0.63473139 |
| 76 | RIPK1 | 0.60721884 |
| 77 | MAP2K6 | 0.60383470 |
| 78 | CSF1R | 0.59486589 |
| 79 | PRKCB | 0.59146811 |
| 80 | MAPK7 | 0.58969285 |
| 81 | PRKACB | 0.57714024 |
| 82 | RPS6KA3 | 0.56952769 |
| 83 | PDGFRB | 0.55524586 |
| 84 | CSNK1G1 | 0.54528658 |
| 85 | PTK2 | 0.54112767 |
| 86 | CSNK1E | 0.54000276 |
| 87 | SGK1 | 0.53736501 |
| 88 | TGFBR2 | 0.53552425 |
| 89 | IKBKE | 0.52708139 |
| 90 | PRKCQ | 0.52681245 |
| 91 | PIM2 | 0.50988645 |
| 92 | SGK2 | 0.50899797 |
| 93 | PDPK1 | 0.50587019 |
| 94 | JAK3 | 0.50343282 |
| 95 | SRC | 0.47496393 |
| 96 | GRK1 | 0.46138704 |
| 97 | IGF1R | 0.45745641 |
| 98 | CSNK1D | 0.45046662 |
| 99 | PKN1 | 0.44747276 |
| 100 | ZAP70 | 0.44597594 |
| 101 | MAP3K13 | 0.44150849 |
| 102 | RET | 0.43653762 |
| 103 | EPHA4 | 0.42359566 |
| 104 | CDK9 | 0.42348739 |
| 105 | MAP3K5 | 0.41693450 |
| 106 | PRKCE | 0.41252530 |
| 107 | PRKCG | 0.39926526 |
| 108 | ICK | 0.39308669 |
| 109 | BLK | 0.38886198 |
| 110 | MAP2K1 | 0.38769021 |
| 111 | CDK4 | 0.38263997 |
| 112 | TEC | 0.37109128 |
| 113 | MTOR | 0.37005622 |
| 114 | RPS6KB1 | 0.36472698 |
| 115 | BCR | 0.36386479 |
| 116 | TAOK2 | 0.36029719 |
| 117 | SGK494 | 0.35390392 |
| 118 | SGK223 | 0.35390392 |
| 119 | MAPK10 | 0.34324389 |
| 120 | EGFR | 0.34215632 |
| 121 | PBK | 0.33765021 |
| 122 | MAP3K6 | 0.33611265 |
| 123 | CAMK1G | 0.33497742 |
| 124 | MAPK3 | 0.33381781 |
| 125 | CSNK1G2 | 0.32425755 |
| 126 | PDK1 | 0.32254524 |
| 127 | CAMK4 | 0.30356072 |
| 128 | MAP3K1 | 0.28710933 |
| 129 | CSNK1G3 | 0.28564571 |
| 130 | IRAK1 | 0.27822089 |
| 131 | IRAK2 | 0.26565359 |
| 132 | LATS2 | 0.25788733 |
| 133 | PAK3 | 0.25787220 |
| 134 | PRKCA | 0.25490018 |
| 135 | ABL1 | 0.22553385 |
| 136 | PIK3CA | 0.22365359 |
| 137 | CSNK1A1L | 0.21092294 |
| 138 | PDK3 | 0.19024834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56854329 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.77371430 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38187878 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36696545 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06624601 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.81105866 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70196092 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68262717 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62509155 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53877607 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47882949 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37511874 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24593208 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14502105 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13614134 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06518841 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94037009 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93515461 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92437971 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92390410 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91604110 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84153132 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80237391 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79176251 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76582258 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75804609 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73305346 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71276286 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71057041 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65936083 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59754400 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56853475 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55442909 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48379992 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47928777 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44748323 |
| 37 | * Bile secretion_Homo sapiens_hsa04976 | 1.39853621 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35270776 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34794902 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33311380 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29362650 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28048536 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24275939 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18443218 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18077187 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16201113 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11904427 |
| 48 | * ABC transporters_Homo sapiens_hsa02010 | 1.08167578 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03960175 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03289477 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99075273 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96267506 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95956161 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94123816 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89887809 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85889519 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85209938 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.82219125 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81733393 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77919345 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69217624 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66955753 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63911841 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57801292 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55610332 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45836555 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45163321 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.40452477 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39051776 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.38844288 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24884512 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24632313 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.23427803 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22290295 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20384206 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20220835 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20113274 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15485932 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10794120 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10072017 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01339486 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2654480 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | -0.2455396 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2358598 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2305833 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2288993 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | -0.2253416 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2242055 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2179070 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2146804 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2097965 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2022344 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1950775 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1946979 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1873101 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1805394 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1781228 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1746624 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1606771 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | -0.1590344 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1520033 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1501713 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1368468 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1240082 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1121514 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0952069 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0878932 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0766868 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0624906 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0624752 |

